Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Meningococcal conjugate vaccines: optimizing global impact.

Terranella A, Cohn A, Clark T.

Infect Drug Resist. 2011;4:161-9. doi: 10.2147/IDR.S21545. Epub 2011 Sep 21.

2.

Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.

Soriano-Gabarró M, Rosenstein N, LaForce FM.

J Health Popul Nutr. 2004 Sep;22(3):275-85.

PMID:
15609780
3.

An evaluation of emerging vaccines for childhood meningococcal disease.

Choudhuri D, Huda T, Theodoratou E, Nair H, Zgaga L, Falconer R, Luksic I, Johnson HL, Zhang JS, El Arifeen S, Nelson CB, Borrow R, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S29. doi: 10.1186/1471-2458-11-S3-S29. Review.

4.

The Meningitis Vaccine Project.

LaForce FM, Konde K, Viviani S, Préziosi MP.

Vaccine. 2007 Sep 3;25 Suppl 1:A97-100. Epub 2007 May 7.

PMID:
17521780
5.

Meningococcal conjugate vaccines: efficacy and new combinations.

Sáfadi MA, Barros AP.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S35-44. Review.

6.

Serogroup A meningococcal conjugate vaccines in Africa.

Kristiansen PA, Jørgensen HJ, Caugant DA.

Expert Rev Vaccines. 2015;14(11):1441-58. doi: 10.1586/14760584.2015.1084232. Epub 2015 Aug 31. Review.

PMID:
26358167
7.

A review of vaccine research and development: meningococcal disease.

Girard MP, Preziosi MP, Aguado MT, Kieny MP.

Vaccine. 2006 May 29;24(22):4692-700. Epub 2006 Mar 31. Review.

PMID:
16621189
8.

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.

Caro JJ, Möller J, Getsios D, Coudeville L, El-Hadi W, Chevat C, Nguyen VH, Caro I.

BMC Public Health. 2007 Jun 29;7:130.

9.

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.

LaForce FM, Djingarey M, Viviani S, Preziosi MP.

Hum Vaccin Immunother. 2017 Oct 2:1-5. doi: 10.1080/21645515.2017.1378841. [Epub ahead of print]

PMID:
28968148
10.

Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.

Woods CW, Armstrong G, Sackey SO, Tetteh C, Bugri S, Perkins BA, Rosenstein NE.

Lancet. 2000 Jan 1;355(9197):30-3.

PMID:
10615888
11.

A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines.

Sáfadi MA, Berezin EN, Oselka GW.

J Pediatr (Rio J). 2012 May;88(3):195-202. doi: doi:10.2223/JPED.2167. Epub 2012 May 23. Review.

12.

From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.

Aguado MT, Jodar L, Granoff D, Rabinovich R, Ceccarini C, Perkin GW.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S391-5. doi: 10.1093/cid/civ593. Review.

13.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
14.

Meningococcal disease in international travel: vaccine strategies.

Wilder-Smith A.

J Travel Med. 2005 Apr;12 Suppl 1:S22-9. Review.

15.
16.

Meningococcal conjugate vaccines.

Zimmer SM, Stephens DS.

Expert Opin Pharmacother. 2004 Apr;5(4):855-63. Review.

PMID:
15102568
17.

Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.

Carod Artal FJ.

Int Health. 2015 Jul;7(4):226-7. doi: 10.1093/inthealth/ihv025. Epub 2015 Apr 15.

PMID:
25878213
18.

Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

Hepkema H, Pouwels KB, van der Ende A, Westra TA, Postma MJ.

PLoS One. 2013 May 31;8(5):e65036. doi: 10.1371/journal.pone.0065036. Print 2013.

19.

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.

MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM.

JAMA. 1998 Nov 18;280(19):1685-9.

PMID:
9832000
20.

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.

Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A, Stapley L, England A, Findlow J, Miller E.

Clin Vaccine Immunol. 2010 Jan;17(1):154-9. doi: 10.1128/CVI.00384-09. Epub 2009 Nov 11.

Supplemental Content

Support Center